These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 27614)

  • 1. Pharmacology of beta-(3,4-dimethoxyphenyl)ethyl amine: lack of peripheral and central antidopaminergic properties.
    Jarboe CH; Bannon MJ; Lipson SF
    J Pharm Pharmacol; 1978 Jul; 30(7):450-1. PubMed ID: 27614
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
    Jackson DM
    Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychoactivity of normacromerine in animals.
    Bourn WM; Keller WJ; Bonfiglio JF
    Life Sci; 1978 Sep; 23(11):1175-84. PubMed ID: 713693
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of 3,4-dimethoxyphenylethylamine treated plasma from chronic schizophrenics and controls.
    Bergen JR; Mulhall S; Moorman P
    Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):331-5. PubMed ID: 1162178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitation and disruption by mescaline and 3,4-dimethoxyphenylethylamine of shock avoidance in rats.
    Gorelick DA; Bridger WH
    Psychopharmacology (Berl); 1977 Apr; 52(2):157-63. PubMed ID: 407599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychomimetic compounds in the urine of schizophrenics. I. Study of catechol derivatives: so-called Pink Spot and 3.4-dimethoxyphenylethylamine (DMPEA)].
    Willmann PK; Bidziński A; Jakimow B; Puzyński S
    Psychiatr Pol; 1977; 11(2):143-9. PubMed ID: 887672
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotoninergic mechanism of clonidine and apomorphine interaction.
    Maj J; Mogilnicka E; Palider W
    Pol J Pharmacol Pharm; 1975; 27(1):27-35. PubMed ID: 1167692
    [No Abstract]   [Full Text] [Related]  

  • 8. Actions of dopaminergic agonists on motor function.
    Costall B; Naylor RJ
    Adv Neurol; 1975; 9():285-97. PubMed ID: 1170715
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of antiadrenergic and antidopaminergic drugs on methamphetamine induced changes in motor activity and cerebral glycogen content of mice].
    Estler CJ
    Arzneimittelforschung; 1974 Aug; 24(8):1087-8. PubMed ID: 4278582
    [No Abstract]   [Full Text] [Related]  

  • 10. Some further observations of the effect of beta-phenethylamine on locomotor activity in mice.
    Jackson DM
    J Pharm Pharmacol; 1975 Apr; 27(4):278-80. PubMed ID: 239123
    [No Abstract]   [Full Text] [Related]  

  • 11. TAAR1-dependent effects of apomorphine in mice.
    Sukhanov I; Espinoza S; Yakovlev DS; Hoener MC; Sotnikova TD; Gainetdinov RR
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1683-93. PubMed ID: 24925023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labeling of catechol-O-methyltransferase with N-haloacetyl derivatives.
    Borchardt RT; Thakker DR
    Methods Enzymol; 1977; 46():554-61. PubMed ID: 909444
    [No Abstract]   [Full Text] [Related]  

  • 13. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
    Nohria V
    Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
    [No Abstract]   [Full Text] [Related]  

  • 14. The involvement of noradrenergic systems in the locomotor activity stimulation in mice produced by beta-phenethylamine.
    Jackson DM
    J Pharm Pharmacol; 1974 Aug; 26(8):651-4. PubMed ID: 4155737
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha-methyldopamine derivatives. Synthesis and pharmacology.
    Borgman RJ; Baylor MR; McPhillips JJ; Stitzel RE
    J Med Chem; 1974 Apr; 17(4):427-30. PubMed ID: 4830540
    [No Abstract]   [Full Text] [Related]  

  • 16. The adenosine A2A receptor agonist CGS 21680 exhibits antipsychotic-like activity in Cebus apella monkeys.
    Andersen MB; Fuxe K; Werge T; Gerlach J
    Behav Pharmacol; 2002 Dec; 13(8):639-44. PubMed ID: 12478214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 3,4-dimethoxyphenethylamine derivatives on monoamine oxidase.
    Keller WJ; Ferguson GG
    J Pharm Sci; 1977 Jul; 66(7):1048-50. PubMed ID: 886445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "pink spot", 3,4-dimethoxyphenylethylamine and dopamine. Relationship to Parkinson's disease and to schizophrenia.
    Barbeau A
    Rev Can Biol; 1967 Mar; 26(1):55-79. PubMed ID: 4865100
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of mescaline, 3, 4-dimethoxyphenethylamine and 2, 5-dimethoxy-4-methylamphetamine on rat plasma prolactin: evidence for serotonergic mediation.
    Meltzer HY; Fessler RG; Simonovic M; Fang VS
    Life Sci; 1978 Sep; 23(11):1185-92. PubMed ID: 152377
    [No Abstract]   [Full Text] [Related]  

  • 20. 2,5-Bis(3,4-dimethoxybenzyl)cyclopentylamine, a peripheral dopamine blocking agent.
    Jarboe CH; Lipson SF; Bannon MJ; Dunnigan DA
    J Med Chem; 1978 Dec; 21(12):1318-20. PubMed ID: 569208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.